Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2015 · 10-Q
Revenue$902.00K$902.00K−12.5% vs Q1 2014 Net Income-$21.96M-$21.96MN/M vs Q1 2014 EPS Diluted-$3.19-$3.19N/M vs Q1 2014 Gross Profit$305,000−50.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flow-$5,030,000N/M Free Cash Flowderived-$5,217,000N/M Margins · derivedGross margin33.8%−25.4 pt vs Q1 2014
Operating margin-2327.8%−1401.8 pt vs Q1 2014
Net margin-2434.3%−1425.5 pt vs Q1 2014
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end